[Federal Register Volume 65, Number 101 (Wednesday, May 24, 2000)]
[Notices]
[Page 33576]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-13077]


-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. 731-TA-828 (Final)]


In the Matter of Bulk Aspirin From China; Notice of Commission 
Determination To Conduct a Portion of the Hearing In Camera

AGENCY: U.S. International Trade Commission.

ACTION: Closure of a portion of a Commission hearing.

-----------------------------------------------------------------------

SUMMARY: Upon request of domestic producer Rhodia, 
Inc.(``Petitioner''), the Commission has determined to conduct a 
portion of its hearing in the above-captioned investigation scheduled 
for May 18, 2000, in camera. See Commission rules 207.24(d), 201.13(m) 
and 201.36(b)(4) (19 CFR Secs. 207.24(d), 201.13(m) and 201.36(b)(4)). 
The remainder of the hearing will be open to the public.
    The Commission has determined that the seven-day advance notice of 
the change to a meeting was not possible. See Commission rule 
201.35(a), (c)(1) (19 CFR 201.35(a), (c)(1)).

FOR FURTHER INFORMATION CONTACT: Tina Potuto Kimble, Office of General 
Counsel, U.S. International Trade Commission, telephone 202-205-3116, 
e-mail [email protected].
    Hearing-impaired individuals are advised that information on this 
matter may be obtained by contacting the Commission's TDD terminal on 
202-205-1810.

SUPPLEMENTARY INFORMATION: The Commission believes that Petitioner has 
justified the need for a closed session. Petitioner seeks a closed 
session to allow for a discussion of its financial and operating 
condition and specific customer accounts. In this investigation, the 
aggregate data of the domestic industry are business proprietary 
information (BPI). Because discussion by Petitioner of its own 
operations and of the domestic industry's data will necessitate 
disclosure of BPI, it can only occur if a portion of the hearing is 
held in camera. In making this decision, the Commission nevertheless 
reaffirms its belief that whenever possible its business should be 
conducted in public.
    The hearing will begin with public presentations by Petitioner with 
questions from the Commission. In addition, the hearing will include a 
10-minute in camera session for a confidential presentation by the 
Petitioner (Rhodia) and for questions from the Commission relating to 
the business proprietary information (``BPI''). For any in camera 
session the room will be cleared of all persons except those who have 
been granted access to BPI under a Commission administrative protective 
order (APO) and are included on the Commission's APO service list in 
this investigation. See 19 CFR 201.35(b)(1), (2). The time for the 
petitioners' presentation in the in camera session will be taken from 
their respective overall allotment for the hearing. All persons 
planning to attend the in camera portions of the hearing should be 
prepared to present proper identification.

    Authority: The General Counsel has certified, pursuant to 
Commission Rule 201.39 (19 C.F.R. 201.39) that, in her opinion, a 
portion of the Commission's hearing in Bulk Aspirin from China, Inv. 
No. 731-TA-828 (Final) may be closed to the public to prevent the 
disclosure of BPI.

    Issued: May 17, 2000

    By order of the Commission.
Donna R. Koehnke,
Secretary.
[FR Doc. 00-13077 Filed 5-23-00; 8:45 am]
BILLING CODE 7020-02-P